Speciality-pharmaceutical firm is looking to raise funds to repay debt and build up working capital.
via WSJ.com: US Business http://online.wsj.com/article/SB10001424052702303799404579282102865248762.html?mod=pls_whats_news_us_business_f
via WSJ.com: US Business http://online.wsj.com/article/SB10001424052702303799404579282102865248762.html?mod=pls_whats_news_us_business_f
Nessun commento:
Posta un commento